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Building a Transporter: Toward the Chemical Semisynthesis of Integral
Membrane Protein Transporters
Paul J. Focke, Francis I. Valiyaveetil.
OHSU, Portland, OR, USA.
Recent years have seen remarkable progress in the elucidation of crystal struc-
tures of a number of transporters. Notable examples include 1) GltPh, an arche-
bacterial orthologue of the aspartate/glutamate and neutral amino acid family 2)
LeuT, a eubacterial orthologue of the glycine/GABA and biogenic amine fam-
ily, and 3) LacY, an E. coli permease of the major facilitator superfamily. In-
formation gleaned from these structures raises a number of questions
concerning the mechanism of substrate recognition, ion selectivity and the cou-
pling of ionic gradients to substrate uptake. Addressing these questions requires
the ability to precisely modify the proteins. Chemical synthesis is a very power-
ful method for protein modification as it enables the incorporation of a wide
range of unnatural amino acids and protein backbone modifications. For the
chemical synthesis of these transporters, we are developing a synthetic ap-
proach in which regions of interest, such as the ion binding sites or the substrate
binding pocket, are obtained by peptide synthesis while the rest of the protein is
obtained by recombinant means. We are utilizing GltPh as a model transporter
for the development of our approach and progress towards the synthesis of the
GltPh transporter will be presented.
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Reconstitution of an Arginine-Agmatine Antiporter in an Oriented
System
Ming-Feng Tsai, Christopher Miller.
Brandeis University, Waltham, MA, USA.
The arginine-dependent extreme acid resistance system plays a critical role for
enteric bacteria to survive the harsh gastric environment. At the center of this
multi-protein system is an arginine-agmatine antiporter called AdiC. To main-
tain cytoplasmic pH, AdiC imports arginine and exports its decarboxylated
product agmatine, resulting in a net extrusion of one proton in each turnover.
An obstacle to quantifying AdiC’s transport mechanism is the random orien-
tation of AdiC protein in reconstituted liposomes. To overcome this problem,
we introduced a mutation, S26C, near the substrate-binding site. This mutant
exhibits similar substrate recognition and pH-dependent activity as wild-type
protein, but loses function completely upon reaction with MTS reagents. The
membrane-impermeant MTSES can then be used as a cleanly sided inhibitor
to ‘‘silence’’ those S26C-AdiC proteins whose extracellular portion projects
from the external side of the liposome. Alternatively, the membrane-
permeant MTSEA and membrane-impermeant reducing reagent, TCEP, can
be used together to inhibit proteins in the opposite orientation. With this ap-
proach, we demonstrate that the activity of AdiC increases to a plateau at
pH 4 as the extracellular side is acidified. Interestingly, the optimal pH for
the cytoplasmic side is 5.5 and further acidification strongly inhibits AdiC’s
function. These findings recapitulate the gastric environment where the extra-
cellular and cytoplasmic pH of bacteria are 2-4 and 5-6, respectively. Steady-
state kinetic analysis found that for both sides of AdiC, the Michaelis-Menten
constants of arginine and agmatine are in the same range. Competition exper-
iments show that argininamide, which mimics the carboxylate-protonated
form of arginine, suppresses arginine transport more effectively from the cy-
toplasmic side. This oriented system allows more precise analysis of AdiC-
mediated substrate transport than has been previously available and permits
comparison to the situation experienced by the bacterial membrane under
acid stress.
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Characterization of a Novel CLC Homolog from Citrobacter Koseri
Sabrina Phillips1, Ashley Lajoie2, Luis Rodriguez1, Kimberly I. Matulef1.
1University of San Diego, San Diego, CA, USA, 2Brandeis University,
Waltham, MA, USA.
CLC chloride-transport proteins are expressed ubiquitously and are vital to sev-
eral physiological processes. This family is distinctive in that some members
are chloride ion channels while others are chloride/proton antiporters. To better
understand the mechanistic similarities and differences between CLC proteins,
we have characterized a novel bacterial homolog from Citrobacter koseri called
CLC-b. CLC-b is 24% identical and 42% similar in amino acid sequence to
CLC-ec1, but lacks several amino acids near the chloride binding sites that
are conserved in most CLCs. Despite lacking these regions, we found that
CLC-b does transport chloride ions. CLC-b contains an isoleucine at the posi-
tion equivalent to the intracellular proton transfer glutamate (E203 in CLC-
ec1). Since all known CLC ion channels contain a hydrophobic residue at
this position whereas all antiporters contain a protonatable residue at this posi-tion, we had hypothesized that CLC-b would be an ion channel. To our surprise,
we found that CLC-b is a chloride/proton antiporter. Hence, a protonatable res-
idue at the intracellular glutamate position is not necessary for proton transfer.
We are currently working to test the ion selectivity and the effects of introduc-
ing a glutamate at this position.
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Characterization of a Novel CLC-ec1 Inhibitor
Kimberly I. Matulef1, Andrew Howery2, R. Lea Sanford3, Sabrina Phillips1,
Sierra Simpson2, Sherwin Abraham2, Julian Whitelegge4, Justin Du Bois2,
Olaf S. Andersen3, Merritt Maduke2.
1University of San Diego, San Diego, CA, USA, 2Stanford University,
Stanford, CA, USA, 3Cornell University, New York, NY, USA,
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CLC chloride channels and transporters are vital to many physiological pro-
cesses. Defects in these proteins can lead to diseases that affect muscle, cardio-
vascular system, kidneys, and bones. Historically, high affinity inhibitors have
played crucial roles in the characterization of ion transporter structure and func-
tion and in the treatment of disease. However, there is a dearth of known CLC
inhibitors. To search for improved inhibitors, we synthesized derivatives of
DIDS (4,4’-diisothio-cyanostilbene-2,2’-disulfonic acid), a small molecule
that inhibits several CLC proteins with low affinity and specificity. We found
that linking DIDS and octanoic acid generated a CLC-ec1 inhibitor (OADS)
that inhibits CLC-ec1 with low micromolar affinity. We are characterizing
the mechanism of inhibition using flux assays, electrophysiology, isothermal
titration calorimetry, photoaffinity labeling, and mutagenesis. Given that
OADS and OADS derivatives that inhibit ClC-ec1 are rather hydrophobic,
we also explored their potential to alter lipid bilayer properties using a gramici-
din based fluorescence assay.
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Structural Investigations of ClC-ec1, a Large Integral Membrane Protein,
using Solution-State NMR and Nanodisc Technology
Thomas A. Chew1,2, Sherwin J. Abraham2, Shelley M. Elvington2,
Merritt C. Maduke2.
1University of California, San Diego, La Jolla, CA, USA,
2Stanford University, Stanford, CA, USA.
CLC antiporters mediate Cl-/Hþ exchange across cell membranes in organisms
ranging from bacteria to mammals. This exchange is accomplished through el-
egant coupling of protein conformational changes to ion binding, unbinding
and translocation events. To understand this mechanism, molecular details of
the different conformations and the dynamics of their interchange must be
known. While X-ray crystallographic structures have provided essential molec-
ular pictures, the details of protein conformational change have remained elu-
sive. To address this issue, we are using solution-state NMR to probe
conformational change in ClC-ec1, a well-characterized CLC homolog of
known structure. Selective 13C labeling of lysine residues and the N-terminus
is achieved by post-translational reductive methylation. 1H-13C HSQC spectra
of these samples reveal reversible, substrate-dependent spectral changes that
may reflect protein conformational changes (studies in progress). A chronic
concern with the use of detergent-solubilized protein is the possible effects
of the non-native detergent environment. To address this concern we are also
implementing nanodisc technology. Nanodiscs present a promising alternative
for studying membrane proteins such as CLCs, offering both a native bilayer
environment and a size small enough for solution-state NMR studies. Each
disc consists of two amphipathic helices wrapped around a bilayer patch of
lipids surrounding the membrane-embedded protein. The protocol for the incor-
poration of the monomeric, 13C-methylated mutant form of ClC-ec1 was opti-
mized and the samples tested for homogeneity and monodispersity. The 1H-13C
HSQC spectra of methylated, monomeric ClC-ec1 in nanodiscs are being in-
vestigated, with preliminary results indicating substrate-dependent spectral
changes in this system. While further experiments will be needed to determine
if these spectral changes represent functionally-relevant conformational
changes, these studies demonstrate the potential for using solution-state
NMR and nanodisc technology to study ClC-ec1 structure in a native lipid
environment.
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Monitoring Substrate-Driven Conformational Changes of ClC-ec1 by
[Methyl-13C] Methionine NMR
Ricky C.K. Cheng, Shelley M. Elvington, Merritt C. Maduke.
Stanford University, Stanford, CA, USA.
ClC-ec1, a bacterial Cl-/Hþ antiporter of the CLC family, has been crystallized
under many conditions. Yet, only one major conformation of the protein has
